A vaccine with virus-like nanoparticles is an effective treatment for RSV

A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University.

Their findings suggest this vaccine induces long-term protection against RSV and could be a novel treatment option for this disease. There is no licensed RSV vaccine.